Velsipity 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL5J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,343
Award facts
- Contract value 100% obligated
- $24,343.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,343.03 on January 27, 2026, for the supply of Velsipity 2 mg tablets (30-count units) to support federal medical procurement needs. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency (DLA) and will be performed at the company's corporate office location in Conshohocken, PA, with an ultimate completion date of January 28, 2026. The delivery order is issued under AmerSourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), which holds the parent indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2031. This strategic contracting structure allows the pharmaceutical distributor to efficiently fulfill federal medical supply requirements across multiple therapeutic domains, supporting critical military healthcare operations, the Defense Health Agency, and other government healthcare systems. The company's consistent receipt of competitively awarded contracts demonstrates its capability to meet federal procurement standards for essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FFL5J?
SPE2DR26FFL5J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FFL5J worth?
The government has obligated $24,343 on SPE2DR26FFL5J.
Is contract SPE2DR26FFL5J an order under another contract?
Yes. SPE2DR26FFL5J is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL5J competed?
The extent of competition for SPE2DR26FFL5J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award